Powered by

ArcherDX Announces the Appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the Board of Directors

May 29, 2019 - PR Newswire
Board and Executive Moves

PR Newswire

 ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, today announced the appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the ArcherDX Board of Directors. 

"Since joining our board last year, Steve has had a tremendous impact on our organization. We look forward to working with him in this expanded capacity," said Jason Myers, co-founder and Chief Execu...